Article
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology.
Experimental and molecular pathology - 1 Aug 2017
Minervini Crescenzio F, Cumbo Cosimo, Orsini Paola, Anelli Luisa, Zagaria Antonella, Impera Luciana, Coccaro Nicoletta, Brunetti Claudia, Minervini Angela, Casieri Paola, Tota Giuseppina, Russo Rossi Antonella, Specchia Giorgina, Albano Francesco
Abstract excerpt
We report a third-generation sequencing assay on nanopore technology (MinION) for detecting BCR-ABL1 KD mutations and compare the results to a Sanger sequencing(SS)-based test in 24 Philadelphia-positive (Ph+) leukemia cases. Our data indicates that MinION is markedly superior to SS in terms of sensitivity, costs and timesaving, and has the added advantage of determining the clonal configuration of multiple...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
